Cargando…

IgE reactivity to vaccine components in dogs that developed immediate-type allergic reactions after vaccination

Allergic reactions after vaccination are considered as an important practical problem in dogs; however, their immunological mechanism has not been well understood. The present study was designed to investigate the relationship between IgE reactivity to the vaccines and immediate-type allergic reacti...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohmori, Keitaro, Masuda, Kenichi, Maeda, Sadatoshi, Kaburagi, Yukiko, Kurata, Keigo, Ohno, Koichi, DeBoer, Douglas J., Tsujimoto, Hajime, Sakaguchi, Masahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112531/
https://www.ncbi.nlm.nih.gov/pubmed/15734545
http://dx.doi.org/10.1016/j.vetimm.2004.12.003
_version_ 1783513492804861952
author Ohmori, Keitaro
Masuda, Kenichi
Maeda, Sadatoshi
Kaburagi, Yukiko
Kurata, Keigo
Ohno, Koichi
DeBoer, Douglas J.
Tsujimoto, Hajime
Sakaguchi, Masahiro
author_facet Ohmori, Keitaro
Masuda, Kenichi
Maeda, Sadatoshi
Kaburagi, Yukiko
Kurata, Keigo
Ohno, Koichi
DeBoer, Douglas J.
Tsujimoto, Hajime
Sakaguchi, Masahiro
author_sort Ohmori, Keitaro
collection PubMed
description Allergic reactions after vaccination are considered as an important practical problem in dogs; however, their immunological mechanism has not been well understood. The present study was designed to investigate the relationship between IgE reactivity to the vaccines and immediate-type allergic reactions after vaccination in dogs. Sera from 10 dogs that developed immediate-type allergic reactions such as circulatory collapse, cyanosis, dyspnea, facial edema, and vomiting within 1 h after vaccination with non-rabies monovalent or combined vaccines and sera from 50 dogs that did not develop allergic reactions after vaccination were collected. Serum IgE reactivity to the injected vaccines was measured by fluorometric ELISA using a mouse monoclonal anti-dog IgE antibody. Then, IgE reactivity to fetal calf serum (FCS) and stabilizer proteins (gelatin, casein, and peptone) included in the vaccines was measured in sera that had high levels of IgE to the vaccines. Levels of serum specific IgE to the vaccines in dogs with immediate-type allergic reactions (59–4173 fluorescence units [FU], mean ± S.D.: 992.5 ± 1181.9 FU) were significantly higher than those in control dogs (38–192 FU, 92.4 ± 43.3 FU) (P < 0.001). Of the eight dogs that developed immediate-type allergic reactions and had high levels of serum specific IgE to the vaccines, seven had specific IgE directed to FCS. The IgE reactivity to the vaccines in sera from these dogs was almost completely inhibited by FCS. The other one dog had serum IgE directed to gelatin and casein included in the vaccine as stabilizers. The results obtained in this study suggest that immediate-type allergic reactions after vaccination in dogs were induced by type I hypersensitivity mediated by IgE directed to vaccine components. In addition, FCS, gelatin, and casein included in vaccines could be the causative allergens that induced immediate-type allergic reactions after vaccination in dogs.
format Online
Article
Text
id pubmed-7112531
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-71125312020-04-02 IgE reactivity to vaccine components in dogs that developed immediate-type allergic reactions after vaccination Ohmori, Keitaro Masuda, Kenichi Maeda, Sadatoshi Kaburagi, Yukiko Kurata, Keigo Ohno, Koichi DeBoer, Douglas J. Tsujimoto, Hajime Sakaguchi, Masahiro Vet Immunol Immunopathol Article Allergic reactions after vaccination are considered as an important practical problem in dogs; however, their immunological mechanism has not been well understood. The present study was designed to investigate the relationship between IgE reactivity to the vaccines and immediate-type allergic reactions after vaccination in dogs. Sera from 10 dogs that developed immediate-type allergic reactions such as circulatory collapse, cyanosis, dyspnea, facial edema, and vomiting within 1 h after vaccination with non-rabies monovalent or combined vaccines and sera from 50 dogs that did not develop allergic reactions after vaccination were collected. Serum IgE reactivity to the injected vaccines was measured by fluorometric ELISA using a mouse monoclonal anti-dog IgE antibody. Then, IgE reactivity to fetal calf serum (FCS) and stabilizer proteins (gelatin, casein, and peptone) included in the vaccines was measured in sera that had high levels of IgE to the vaccines. Levels of serum specific IgE to the vaccines in dogs with immediate-type allergic reactions (59–4173 fluorescence units [FU], mean ± S.D.: 992.5 ± 1181.9 FU) were significantly higher than those in control dogs (38–192 FU, 92.4 ± 43.3 FU) (P < 0.001). Of the eight dogs that developed immediate-type allergic reactions and had high levels of serum specific IgE to the vaccines, seven had specific IgE directed to FCS. The IgE reactivity to the vaccines in sera from these dogs was almost completely inhibited by FCS. The other one dog had serum IgE directed to gelatin and casein included in the vaccine as stabilizers. The results obtained in this study suggest that immediate-type allergic reactions after vaccination in dogs were induced by type I hypersensitivity mediated by IgE directed to vaccine components. In addition, FCS, gelatin, and casein included in vaccines could be the causative allergens that induced immediate-type allergic reactions after vaccination in dogs. Elsevier B.V. 2005-04-08 2005-01-11 /pmc/articles/PMC7112531/ /pubmed/15734545 http://dx.doi.org/10.1016/j.vetimm.2004.12.003 Text en Copyright © 2004 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Ohmori, Keitaro
Masuda, Kenichi
Maeda, Sadatoshi
Kaburagi, Yukiko
Kurata, Keigo
Ohno, Koichi
DeBoer, Douglas J.
Tsujimoto, Hajime
Sakaguchi, Masahiro
IgE reactivity to vaccine components in dogs that developed immediate-type allergic reactions after vaccination
title IgE reactivity to vaccine components in dogs that developed immediate-type allergic reactions after vaccination
title_full IgE reactivity to vaccine components in dogs that developed immediate-type allergic reactions after vaccination
title_fullStr IgE reactivity to vaccine components in dogs that developed immediate-type allergic reactions after vaccination
title_full_unstemmed IgE reactivity to vaccine components in dogs that developed immediate-type allergic reactions after vaccination
title_short IgE reactivity to vaccine components in dogs that developed immediate-type allergic reactions after vaccination
title_sort ige reactivity to vaccine components in dogs that developed immediate-type allergic reactions after vaccination
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112531/
https://www.ncbi.nlm.nih.gov/pubmed/15734545
http://dx.doi.org/10.1016/j.vetimm.2004.12.003
work_keys_str_mv AT ohmorikeitaro igereactivitytovaccinecomponentsindogsthatdevelopedimmediatetypeallergicreactionsaftervaccination
AT masudakenichi igereactivitytovaccinecomponentsindogsthatdevelopedimmediatetypeallergicreactionsaftervaccination
AT maedasadatoshi igereactivitytovaccinecomponentsindogsthatdevelopedimmediatetypeallergicreactionsaftervaccination
AT kaburagiyukiko igereactivitytovaccinecomponentsindogsthatdevelopedimmediatetypeallergicreactionsaftervaccination
AT kuratakeigo igereactivitytovaccinecomponentsindogsthatdevelopedimmediatetypeallergicreactionsaftervaccination
AT ohnokoichi igereactivitytovaccinecomponentsindogsthatdevelopedimmediatetypeallergicreactionsaftervaccination
AT deboerdouglasj igereactivitytovaccinecomponentsindogsthatdevelopedimmediatetypeallergicreactionsaftervaccination
AT tsujimotohajime igereactivitytovaccinecomponentsindogsthatdevelopedimmediatetypeallergicreactionsaftervaccination
AT sakaguchimasahiro igereactivitytovaccinecomponentsindogsthatdevelopedimmediatetypeallergicreactionsaftervaccination